1887

Abstract

subsp. (SDSE) isolates are the most common group C streptococci in humans and reports of invasive infections associated with SDSE have been increasing. Molecular epidemiology studies are an important strategy to trace the emergence and spread of possible well-fit bacterial pathogens of humans and animals. In this work, we analysed the antimicrobial and clonal profiles of 115 SDSE infection and colonization isolates of human and equine origin. PFGE revealed the spread of two main clusters: clone A (57.4 %) and clone A (26.1 %). Remarkably, two isolates from clone B obtained from human colonization cases displayed identical PFGE patterns to those of three equine infection isolates. In addition, multilocus sequence typing allocated these isolates to ST129 (CC31). All of the SDSE isolates were susceptible to penicillin, vancomycin, gentamicin, levofloxacin and chloramphenicol. Tetracycline and erythromycin resistance rates were 65.2 and 13.9 % respectively. Nevertheless, none of the isolates displaying sporadic PFGE patterns showed erythromycin resistance. The majority of erythromycin-resistant isolates from clone A had inducible resistance to macrolides, lincosamines and streptogramins B (iMLS phenotype), which is associated with the presence of the gene, whereas the resistant isolates from clone B showed the M phenotype, associated with the gene. In conclusion, the data indicated that the analysed collection of SDSE isolates displayed a clonal structure and that the isolates found in human colonization cases could also be involved in equine infections.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000052
2015-05-01
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/jmm/64/5/551.html?itemId=/content/journal/jmm/10.1099/jmm.0.000052&mimeType=html&fmt=ahah

References

  1. Ahmad Y., Gertz R. E. Jr, Li Z., Sakota V., Broyles L. N., Van Beneden C., Facklam R., Shewmaker P. L., Reingold A. et al. 2009; Genetic relationships deduced from emm and multilocus sequence typing of invasive Streptococcus dysgalactiae subsp. equisimilis and S. canis recovered from isolates collected in the United States. J Clin Microbiol 47:2046–2054 [View Article][PubMed]
    [Google Scholar]
  2. Beres S. B., Sesso R., Pinto S. W., Hoe N. P., Porcella S. F., Deleo F. R., Musser J. M. 2008; Genome sequence of a Lancefield group C Streptococcus zooepidemicus strain causing epidemic nephritis: new information about an old disease. PLoS One 3:e3026 [View Article][PubMed]
    [Google Scholar]
  3. Biedenbach D. J., Toleman M. A., Walsh T. R., Jones R. N. 2006; Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997–2004). Diagn Microbiol Infect Dis 55:119–127 [View Article][PubMed]
    [Google Scholar]
  4. Bramhachari P. V., Kaul S. Y., McMillan D. J., Shaila M. S., Karmarkar M. G., Sriprakash K. S. 2010; Disease burden due to Streptococcus dysgalactiae subsp. equisimilis (group G and C streptococcus) is higher than that due to Streptococcus pyogenes among Mumbai school children. J Med Microbiol 59:220–223 [View Article][PubMed]
    [Google Scholar]
  5. Brandt C. M., Spellerberg B. 2009; Human infections due to Streptococcus dysgalactiae subspecies equisimilis . Clin Infect Dis 49:766–772 [View Article][PubMed]
    [Google Scholar]
  6. Broyles L. N., Van Beneden C., Beall B., Facklam R., Shewmaker P. L., Malpiedi P., Daily P., Reingold A., Farley M. M. 2009; Population-based study of invasive disease due to beta-hemolytic streptococci of groups other than A and B. Clin Infect Dis 48:706–712 [View Article][PubMed]
    [Google Scholar]
  7. Bruun T., Kittang B. R., de Hoog B. J., Aardal S., Flaatten H. K., Langeland N., Mylvaganam H., Vindenes H. A., Skrede S. 2013; Necrotizing soft tissue infections caused by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis of groups C and G in western Norway. Clin Microbiol Infect 19:E545–E550 [View Article][PubMed]
    [Google Scholar]
  8. Clancy J., Petitpas J., Dib-Hajj F., Yuan W., Cronan M., Kamath A. V., Bergeron J., Retsema J. A. 1996; Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes . Mol Microbiol 22:867–879 [View Article][PubMed]
    [Google Scholar]
  9. CLSI (2014). Performance Standards for Antimicrobial Susceptibility Testing; 24th Informational Supplement M100-S24. Wayne, PA: Clinical and Laboratory Standards Institute
  10. Davies M. R., McMillan D. J., Beiko R. G., Barroso V., Geffers R., Sriprakash K. S., Chhatwal G. S. 2007; Virulence profiling of Streptococcus dysgalactiae subspecies equisimilis isolated from infected humans reveals 2 distinct genetic lineages that do not segregate with their phenotypes or propensity to cause diseases. Clin Infect Dis 44:1442–1454 [View Article][PubMed]
    [Google Scholar]
  11. Duck W. M., Steward C. D., Banerjee S. N., McGowan J. E. Jr, Tenover F. C. 2003; Optimization of computer software settings improves accuracy of pulsed-field gel electrophoresis macrorestriction fragment pattern analysis. J Clin Microbiol 41:3035–3042 [View Article][PubMed]
    [Google Scholar]
  12. Erol E., Locke S. J., Donahoe J. K., Mackin M. A., Carter C. N. 2012; Beta-hemolytic Streptococcus spp. from horses: a retrospective study (2000–2010). J Vet Diagn Invest 24:142–147 [View Article][PubMed]
    [Google Scholar]
  13. Facklam R. 2002; What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev 15:613–630 [View Article][PubMed]
    [Google Scholar]
  14. Fernández E., Blume V., Garrido P., Collins M. D., Mateos A., Domínguez L., Fernández-Garayzábal J. F. 2004; Streptococcus equi subsp. ruminatorum subsp. nov., isolated from mastitis in small ruminants. Int J Syst Evol Microbiol 54:2291–2296 [View Article][PubMed]
    [Google Scholar]
  15. Haenni M., Saras E., Bertin S., Leblond P., Madec J. Y., Payot S. 2010; Diversity and mobility of integrative and conjugative elements in bovine isolates of Streptococcus agalactiae, S. dysgalactiae subsp. dysgalactiae, and S. uberis . Appl Environ Microbiol 76:7957–7965 [View Article][PubMed]
    [Google Scholar]
  16. Kim H. Y., Uh Y. 2004; Macrolide resistance in beta-hemolytic streptococci: changes after the implementation of the separation of prescribing and dispensing of medications policy in Korea. Yonsei Med J 45:591–597 [View Article][PubMed]
    [Google Scholar]
  17. Loubinoux J., Plainvert C., Collobert G., Touak G., Bouvet A., Poyart C. CNR-Strep Network 2013; Adult invasive and noninvasive infections due to Streptococcus dysgalactiae subsp. equisimilis in France from 2006 to 2010. J Clin Microbiol 51:2724–2727 [View Article][PubMed]
    [Google Scholar]
  18. Malhotra-Kumar S., Lammens C., Piessens J., Goossens H. 2005; Multiplex PCR for simultaneous detection of macrolide and tetracycline resistance determinants in streptococci. Antimicrob Agents Chemother 49:4798–4800 [View Article][PubMed]
    [Google Scholar]
  19. McMillan D. J., Bessen D. E., Pinho M., Ford C., Hall G. S., Melo-Cristino J., Ramirez M. 2010; Population genetics of Streptococcus dysgalactiae subspecies equisimilis reveals widely dispersed clones and extensive recombination. PLoS One 5:e11741 [View Article][PubMed]
    [Google Scholar]
  20. Moore E., Arnscheidt A., Krüger A., Strömpl C., Mau M. 2004; Simplified protocols for the preparation of genomic DNA from bacterial cultures. In Molecular Microbial Ecology Manual pp. 3–18 Edited by Kowalchuk G. A., Bruijn F. J., Head I. M., Van der Zijpp A. J., van Elsas J. D. Dordrecht: Kluwer;
    [Google Scholar]
  21. Pacheco A. B., Guth B. E., Soares K. C., Nishimura L., de Almeida D. F., Ferreira L. C. 1997; Random amplification of polymorphic DNA reveals serotype-specific clonal clusters among enterotoxigenic Escherichia coli strains isolated from humans. J Clin Microbiol 35:1521–1525[PubMed]
    [Google Scholar]
  22. Pinho M. D., Melo-Cristino J., Ramirez M. 2006; Clonal relationships between invasive and noninvasive Lancefield group C and G streptococci and emm-specific differences in invasiveness. J Clin Microbiol 44:841–846 [View Article][PubMed]
    [Google Scholar]
  23. Pinho M. D., Melo-Cristino J., Ramirez M. Portuguese Group for the Study of Streptococcal Infections 2010; Fluoroquinolone resistance in Streptococcus dysgalactiae subsp. equisimilis and evidence for a shared global gene pool with Streptococcus pyogenes . Antimicrob Agents Chemother 54:1769–1777 [View Article][PubMed]
    [Google Scholar]
  24. Prabu D., Menon T. 2013; Genotyping of erythromycin resistant group C & G streptococci isolated in Chennai, south India. Indian J Med Res 137:164–168[PubMed]
    [Google Scholar]
  25. Rantala S., Vahakuopus S., Vuopio-Varkila J., Vuento R., Syrjanen J. 2010; Streptococcus dysgalactiae subsp. equisimilis bacteremia, Finland, 1995–2004. Emerg Infect Dis 16:843–846 [View Article][PubMed]
    [Google Scholar]
  26. Rato M. G., Bexiga R., Nunes S. F., Vilela C. L., Santos-Sanches I. 2010; Human group A streptococci virulence genes in bovine group C streptococci. Emerg Infect Dis 16:116–119 [View Article][PubMed]
    [Google Scholar]
  27. Reissmann S., Gillen C. M., Fulde M., Bergmann R., Nerlich A., Rajkumari R., Brahmadathan K. N., Chhatwal G. S., Nitsche-Schmitz D. P. 2012; Region specific and worldwide distribution of collagen-binding M proteins with PARF motifs among human pathogenic streptococcal isolates. PLoS One 7:e30122 [View Article][PubMed]
    [Google Scholar]
  28. Schrieber L., Towers R., Muscatello G., Speare R. 2014; Transmission of Streptococcus dysgalactiae subsp. equisimilis between child and dog in an Aboriginal Australian community. Zoonoses Public Health 61:145–148 [View Article][PubMed]
    [Google Scholar]
  29. Seppälä H., Skurnik M., Soini H., Roberts M. C., Huovinen P. 1998; A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes . Antimicrob Agents Chemother 42:257–262[PubMed] [CrossRef]
    [Google Scholar]
  30. Shulman S. T., Bisno A. L., Clegg H. W., Gerber M. A., Kaplan E. L., Lee G., Martin J. M., Van Beneden C. 2012; Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis 55:1279–1282 [View Article][PubMed]
    [Google Scholar]
  31. Sunaoshi K., Murayama S. Y., Adachi K., Yagoshi M., Okuzumi K., Chiba N., Morozumi M., Ubukata K. 2010; Molecular emm genotyping and antibiotic susceptibility of Streptococcus dysgalactiae subsp. equisimilis isolated from invasive and non-invasive infections. J Med Microbiol 59:82–88 [View Article][PubMed]
    [Google Scholar]
  32. Sutcliffe J., Grebe T., Tait-Kamradt A., Wondrack L. 1996; Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 40:2562–2566[PubMed]
    [Google Scholar]
  33. Suzuki H., Lefébure T., Hubisz M. J., Pavinski Bitar P., Lang P., Siepel A., Stanhope M. J. 2011; Comparative genomic analysis of the Streptococcus dysgalactiae species group: gene content, molecular adaptation, and promoter evolution. Genome Biol Evol 3:168–185 [View Article][PubMed]
    [Google Scholar]
  34. Takahashi T., Asami R., Tanabe K., Hirono Y., Nozawa Y., Takahashi T., Chiba N., Ubukata K. 2010; Clinical aspects of invasive infection with Streptococcus dysgalactiae subsp. equisimilis in elderly patients. J Infect Chemother 16:68–71 [View Article][PubMed]
    [Google Scholar]
  35. Takahashi T., Ubukata K., Watanabe H. 2011; Invasive infection caused by Streptococcus dysgalactiae subsp. equisimilis: characteristics of strains and clinical features. J Infect Chemother 17:1–10 [View Article][PubMed]
    [Google Scholar]
  36. Tsai C.-T., Chi C.-Y., Ho C.-M., Lin P.-C., Chou C.-H., Wang J.-H., Wang J.-H., Lin H.-C., Tien N. et al. 2014; Correlation of virulence genes to clinical manifestations and outcome in patients with Streptococcus dysgalactiae subspecies equisimilis bacteremia. J Microbiol Immunol Infect 47:462–468 [View Article][PubMed]
    [Google Scholar]
  37. Van Leer Buter C. C., Mouton J. W., Klaassen C. H. W., Handgraaf C. M. A., Sunnen S., Melchers W. J. G., Sturm P. D. J. 2010; Prevalence and molecular mechanism of macrolide resistance in beta-haemolytic streptococci in The Netherlands. Int J Antimicrob Agents 35:590–592 [View Article][PubMed]
    [Google Scholar]
  38. Vandamme P., Pot B., Falsen E., Kersters K., Devriese L. A. 1996; Taxonomic study of lancefield streptococcal groups C, G, and L (Streptococcus dysgalactiae) and proposal of S. dysgalactiae subsp. equisimilis subsp. nov.. Int J Syst Bacteriol 46:774–781 [View Article][PubMed]
    [Google Scholar]
  39. Watanabe S., Kirikae T., Miyoshi-Akiyama T. 2013; Complete genome sequence of Streptococcus dysgalactiae subsp. equisimilis 167 carrying Lancefield group C antigen and comparative genomics of S. dysgalactiae subsp. equisimilis strains. Genome Biol Evol 5:1644–1651 [View Article][PubMed]
    [Google Scholar]
  40. Weisblum B. 1995; Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother 39:577–585 [View Article][PubMed]
    [Google Scholar]
  41. Yin J., Yu S., Liu X., Li Y., Gao W., Zhou L., Ji L., Shen X., Yang Y. 2012; Molecular characterization of group G Streptococcus dysgalactiae subsp. equisimilis recovered from patients and healthy people in China. Diagn Microbiol Infect Dis 72:41–46 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000052
Loading
/content/journal/jmm/10.1099/jmm.0.000052
Loading

Data & Media loading...

Supplements

Supplementary Data

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error